New clinical trial to treat skin disorder begins
Thursday, March 17, 2011 - 11:30
in Health & Medicine
A Phase II trial to treat skin erosions in patients suffering from the severe genetic skin disorder, Recessive Dystrophic Epidermolysis Bullosa (RDEB), begins today, led by a team of scientists and clinicians at Kings Health Partners.
